KISS1R and breast cancer: Our results suggest that placental factors may reduce breast cancer progression depending on ER status of cancerous cells and support the concept that it is the ER status of mammary cells that dictates whether or not KISS1R may be a novel clinical target for treating breast cancer metastasis.